9-aminocamptothecin has been researched along with Germinoblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheson, BD; Phillips, PH; Wilson, WH | 1 |
| Cheson, BD; Elwood, P; Humphrey, R; Jaffe, ES; Kohler, DR; Little, R; Pearson, D; Steinberg, SM; Wilson, WH | 1 |
1 trial(s) available for 9-aminocamptothecin and Germinoblastoma
| Article | Year |
|---|---|
Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Camptothecin; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Lymphoma; Male; Maximum Allowable Concentration; Middle Aged; Recurrence | 1998 |
2 other study(ies) available for 9-aminocamptothecin and Germinoblastoma
| Article | Year |
|---|---|
Clinical trials referral resource. Clinical trials with 9-aminocamptothecin.
Topics: Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Colonic Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neutropenia | 1995 |
Clinical trials at the medicine branch of the NCI-part 2.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Central Nervous System Neoplasms; Clinical Trials as Topic; Eye Neoplasms; Humans; Immunotherapy; Lymphoma; Lymphoma, Non-Hodgkin; Recurrence | 1995 |